Peleg Rider

2.4k total citations
24 papers, 1.9k citations indexed

About

Peleg Rider is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Peleg Rider has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Peleg Rider's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). Peleg Rider is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). Peleg Rider collaborates with scholars based in Israel, United States and Germany. Peleg Rider's co-authors include Ron N. Apte, Yaron Carmi, Elena Voronov, Idan Cohen, Charles A. Dinarello, Malka R. White, Alex Braiman, Shahar Dotan, Ofer Guttman and Irena Kaplanov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Peleg Rider

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peleg Rider Israel 15 1.0k 751 278 204 196 24 1.9k
Malka R. White Israel 7 912 0.9× 719 1.0× 344 1.2× 172 0.8× 185 0.9× 7 1.6k
Stefan K. Drexler Switzerland 18 1.2k 1.2× 1.2k 1.6× 197 0.7× 173 0.8× 275 1.4× 25 2.5k
Outi Elomaa Finland 23 915 0.9× 625 0.8× 202 0.7× 140 0.7× 164 0.8× 37 1.9k
Zohreh Babaloo Iran 27 880 0.9× 691 0.9× 362 1.3× 113 0.6× 162 0.8× 98 2.4k
Dror Luger United States 23 1.1k 1.1× 493 0.7× 237 0.9× 263 1.3× 257 1.3× 36 2.8k
Giovanna Leoni United States 22 804 0.8× 1.1k 1.4× 158 0.6× 276 1.4× 143 0.7× 36 2.1k
Raúl Elgueta United States 20 1.6k 1.6× 676 0.9× 502 1.8× 147 0.7× 215 1.1× 28 2.6k
So‐Youn Min South Korea 31 1.1k 1.0× 707 0.9× 496 1.8× 120 0.6× 116 0.6× 50 2.5k
Shahar Dotan Israel 17 1.2k 1.2× 1.0k 1.4× 536 1.9× 202 1.0× 386 2.0× 20 2.4k
Toshihiko Okazaki Japan 14 930 0.9× 737 1.0× 352 1.3× 214 1.0× 212 1.1× 26 1.9k

Countries citing papers authored by Peleg Rider

Since Specialization
Citations

This map shows the geographic impact of Peleg Rider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peleg Rider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peleg Rider more than expected).

Fields of papers citing papers by Peleg Rider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peleg Rider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peleg Rider. The network helps show where Peleg Rider may publish in the future.

Co-authorship network of co-authors of Peleg Rider

This figure shows the co-authorship network connecting the top 25 collaborators of Peleg Rider. A scholar is included among the top collaborators of Peleg Rider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peleg Rider. Peleg Rider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Milyavsky, Michael, Shahar Dotan, Claudia Waskow, et al.. (2023). T Cells Expressing a Modified FcγRI Exert Antibody-Dependent Cytotoxicity and Overcome the Limitations of CAR T-cell Therapy against Solid Tumors. Cancer Immunology Research. 11(6). 792–809. 2 indexed citations
3.
Netanely, Dvir, Ron Shamir, Rachel Blau, et al.. (2020). Melanoma-Secreted Lysosomes Trigger Monocyte-Derived Dendritic Cell Apoptosis and Limit Cancer Immunotherapy. Cancer Research. 80(10). 1942–1956. 25 indexed citations
4.
Ozeri, Eyal, Peleg Rider, Galit Shahaf, et al.. (2020). Differential signaling patterns of stimulated bone marrow-derived dendritic cells under α1-antitrypsin-enriched conditions. Cellular Immunology. 361. 104281–104281. 4 indexed citations
5.
Wine, Yariv, Haim Gutman, Alexander Tsivian, et al.. (2019). A distinct subset of FcγRI-expressing Th1 cells exert antibody-mediated cytotoxic activity. Journal of Clinical Investigation. 129(10). 4151–4164. 7 indexed citations
6.
Schuster, Ronen, Peleg Rider, David Greenberg, et al.. (2019). S-Nitrosylation of α1-Antitrypsin Triggers Macrophages Toward Inflammatory Phenotype and Enhances Intra-Cellular Bacteria Elimination. Frontiers in Immunology. 10. 590–590. 14 indexed citations
7.
8.
9.
Rider, Peleg, Elena Voronov, Charles A. Dinarello, Ron N. Apte, & Idan Cohen. (2017). Alarmins: Feel the Stress. The Journal of Immunology. 198(4). 1395–1402. 134 indexed citations
10.
Rider, Peleg, Yaron Carmi, & Idan Cohen. (2016). Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations. International Journal of Cell Biology. 2016. 1–11. 152 indexed citations
11.
Guttman, Ofer, et al.. (2016). Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin. Frontiers in Immunology. 7. 559–559. 15 indexed citations
12.
Rider, Peleg, Yaron Carmi, Rami Yossef, et al.. (2015). IL-1 Receptor Antagonist Chimeric Protein: Context-Specific and Inflammation-Restricted Activation. The Journal of Immunology. 195(4). 1705–1712. 10 indexed citations
13.
Cohen, Idan, Peleg Rider, Marina A. Freudenberg, et al.. (2015). IL-1α is a DNA damage sensor linking genotoxic stress signaling to sterile inflammation and innate immunity. Scientific Reports. 5(1). 14756–14756. 69 indexed citations
14.
15.
Bersudsky, Marina, Daniel Fishman, Rosalyn M. White, et al.. (2013). Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice. Gut. 63(4). 598–609. 197 indexed citations
16.
Rider, Peleg, Yaron Carmi, Elena Voronov, & Ron N. Apte. (2013). Interleukin-1α. Seminars in Immunology. 25(6). 430–438. 133 indexed citations
17.
Rider, Peleg, Irena Kaplanov, Marianna Romžová, et al.. (2012). The transcription of the alarmin cytokine interleukin-1 alpha is controlled by hypoxia inducible factors 1 and 2 alpha in hypoxic cells. Frontiers in Immunology. 3. 290–290. 51 indexed citations
18.
Carmi, Yaron, Shahar Dotan, Moshe Elkabets, et al.. (2011). Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis. The Journal of Immunology. 186(6). 3462–3471. 89 indexed citations
19.
Cohen, Idan, Peleg Rider, Yaron Carmi, et al.. (2010). Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proceedings of the National Academy of Sciences. 107(6). 2574–2579. 279 indexed citations
20.
Duncan, Kathleen E., et al.. (2001). Analysis of a Microbial Community Oxidizing Inorganic Sulfide and Mercaptans. Biotechnology Progress. 17(4). 768–774. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malka R. White Breakdown of academic impact, for papers by Stefan K. Drexler Breakdown of academic impact, for papers by Outi Elomaa Breakdown of academic impact, for papers by Zohreh Babaloo Breakdown of academic impact, for papers by Dror Luger Breakdown of academic impact, for papers by Giovanna Leoni Breakdown of academic impact, for papers by Raúl Elgueta Breakdown of academic impact, for papers by So‐Youn Min Breakdown of academic impact, for papers by Shahar Dotan Breakdown of academic impact, for papers by Toshihiko Okazaki
Rankless by CCL
2026